PARIS, France, July 23, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing ...
Chanson International Holding announced an $8 million public offering to fund new store openings in China and the U.S. Chanson International Holding has announced a best-efforts public offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results